{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T16:27:58Z","timestamp":1793550478026,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["A29799"],"award-info":[{"award-number":["A29799"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["DRCNPG-Jun22\\u2216100007"],"award-info":[{"award-number":["DRCNPG-Jun22\\u2216100007"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_PC_21042"],"award-info":[{"award-number":["MC_PC_21042"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["STAR Protocols"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.xpro.2026.104872","type":"journal-article","created":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T05:51:34Z","timestamp":1791006694000},"page":"104872","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Modeling human tumor evolution in mice"],"prefix":"10.1016","volume":"7","author":[{"given":"Dale M.","family":"Watt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise E.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Leah","family":"Etheridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip D.","family":"Dunne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9304-439X","authenticated-orcid":false,"given":"Karen","family":"Blyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xpro.2026.104872_bib1","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.cell.2017.01.018","article-title":"Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future","volume":"168","author":"McGranahan","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.xpro.2026.104872_bib2","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nature10762","article-title":"Clonal evolution in cancer","volume":"481","author":"Greaves","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.xpro.2026.104872_bib3","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1126\/science.1235122","article-title":"Cancer genome landscapes","volume":"339","author":"Vogelstein","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.xpro.2026.104872_bib4","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a041736","article-title":"The Evolution of Mouse Models of Cancer: Past, Present, and Future","volume":"15","author":"Abate-Shen","year":"2025","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.xpro.2026.104872_bib5","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0092-8674(90)90186-I","article-title":"A genetic model for colorectal tumorigenesis","volume":"61","author":"Fearon","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.xpro.2026.104872_bib6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/ng.3214","article-title":"A Big Bang model of human colorectal tumor growth","volume":"47","author":"Sottoriva","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xpro.2026.104872_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095236","article-title":"Conditional reverse tet-transactivator mouse strains for the efficient induction of TRE-regulated transgenes in mice","volume":"9","author":"Dow","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.xpro.2026.104872_bib8","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.77987","article-title":"Rapid and specific degradation of endogenous proteins in mouse models using auxin-inducible degrons","volume":"11","author":"Macdonald","year":"2022","journal-title":"eLife"},{"key":"10.1016\/j.xpro.2026.104872_bib9","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/35074129","article-title":"Somatic activation of the K-ras oncogene causes early onset lung cancer in mice","volume":"410","author":"Johnson","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.xpro.2026.104872_bib10","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/s41416-023-02157-6","article-title":"MmCMS: mouse models' consensus molecular subtypes of colorectal cancer","volume":"128","author":"Amirkhah","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.xpro.2026.104872_bib11","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/nm.3967","article-title":"The consensus molecular subtypes of colorectal cancer","volume":"21","author":"Guinney","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.xpro.2026.104872_bib12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ccell.2019.08.003","article-title":"Epithelial NOTCH Signaling Rewires the Tumor Microenvironment of Colorectal Cancer to Drive Poor-Prognosis Subtypes and Metastasis","volume":"36","author":"Jackstadt","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xpro.2026.104872_bib13","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1038\/s41556-025-01763-1","article-title":"NOX1 and NPY1R mark regional colon stem cell populations that serve as cancer origins in vivo","volume":"27","author":"Gasnier","year":"2025","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.xpro.2026.104872_bib14","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1038\/s41467-021-23717-5","article-title":"Oncogenic BRAF, unrestrained by TGFbeta-receptor signalling, drives right-sided colonic tumorigenesis","volume":"12","author":"Leach","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xpro.2026.104872_bib15","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41586-025-09916-w","article-title":"MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistance","volume":"650","author":"White","year":"2026","journal-title":"Nature"},{"key":"10.1016\/j.xpro.2026.104872_bib16","doi-asserted-by":"crossref","first-page":"264","DOI":"10.14740\/gr1062w","article-title":"Difference Between Left-Sided and Right-Sided Colorectal Cancer: A Focused Review of Literature","volume":"11","author":"Baran","year":"2018","journal-title":"Gastroenterol. Res."},{"key":"10.1016\/j.xpro.2026.104872_bib17","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s41588-024-01654-5","article-title":"Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer","volume":"56","author":"Malla","year":"2024","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xpro.2026.104872_bib18","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41588-025-02408-7","article-title":"Nucleophosmin supports WNT-driven hyperproliferation and tumor initiation","volume":"58","author":"Kanellos","year":"2026","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xpro.2026.104872_bib19","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/s41586-024-08053-0","article-title":"Polyclonality overcomes fitness barriers in Apc-driven tumorigenesis","volume":"634","author":"Sadien","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.xpro.2026.104872_bib20","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.stem.2022.07.008","article-title":"Dynamic and adaptive cancer stem cell population admixture in colorectal neoplasia","volume":"29","author":"Vasquez","year":"2022","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xpro.2026.104872_bib21","article-title":"Unraveling Pancreatic Cancer: Epidemiology, Risk Factors, and Global Trends","volume":"16","author":"Qadir","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.xpro.2026.104872_bib22","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ccr.2005.04.023","article-title":"Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice","volume":"7","author":"Hingorani","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xpro.2026.104872_bib23","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1158\/2159-8290.CD-24-0177","article-title":"Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer","volume":"14","author":"Dilly","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xpro.2026.104872_bib24","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","article-title":"Pancreatic cancer: Advances and challenges","volume":"186","author":"Halbrook","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.xpro.2026.104872_bib25","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1158\/1078-0432.CCR-25-0821","article-title":"KRAS Inhibitors in Pancreas Cancer: Facts and Hopes about the Immunotherapy We've All Been Waiting For","volume":"32","author":"Stanger","year":"2026","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xpro.2026.104872_bib26","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1158\/2159-8290.CD-25-0349","article-title":"Response and Resistance to RAS Inhibition in Cancer","volume":"15","author":"Ebright","year":"2025","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xpro.2026.104872_bib27","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1158\/0008-5472.CAN-22-2119","article-title":"Dual Recombinase-Based Mouse Models Help Decipher Cancer Biology and Targets for Therapy","volume":"83","author":"Sket","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.xpro.2026.104872_bib28","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ccell.2021.02.007","article-title":"Type I collagen deletion in alphaSMA(+) myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer","volume":"39","author":"Chen","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xpro.2026.104872_bib29","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/s41586-025-08585-z","article-title":"Human-correlated genetic models identify precision therapy for liver cancer","volume":"639","author":"M\u00fcller","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.xpro.2026.104872_bib30","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2024.2330194","article-title":"Co-inhibition of TGF-beta and PD-L1 pathways in a metastatic colorectal cancer mouse model triggers interferon responses, innate cells and T cells, alongside metabolic changes and tumor resistance","volume":"13","author":"Nair","year":"2024","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.xpro.2026.104872_bib31","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008086","article-title":"Clinically relevant orthotopic pancreatic cancer models for adoptive T cell transfer therapy","volume":"12","author":"Horvat","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.xpro.2026.104872_bib32","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nature07935","article-title":"Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche","volume":"459","author":"Sato","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.xpro.2026.104872_bib33","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.cell.2014.12.021","article-title":"Organoid models of human and mouse ductal pancreatic cancer","volume":"160","author":"Boj","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.xpro.2026.104872_bib34","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1084\/jem.20162024","article-title":"Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer","volume":"214","author":"\u00d6hlund","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.xpro.2026.104872_bib35","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/s41586-025-09125-5","article-title":"Loss of colonic fidelity enables multilineage plasticity and metastasis","volume":"644","author":"Cammareri","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.xpro.2026.104872_bib36","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/978-1-0716-0747-3_20","article-title":"An Intrasplenic Injection Model for the Study of Cancer Stem Cell Seeding Capacity","volume":"2171","author":"Dafflon","year":"2020","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.xpro.2026.104872_bib37","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1158\/2159-8290.CD-25-0679","article-title":"A Plastic EMP1+ to LGR5+ Cell State Conversion as a Bypass to KRASG12D Pharmacologic Inhibition in Metastatic Colorectal Cancer","volume":"16","author":"Centonze","year":"2026","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xpro.2026.104872_bib38","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41586-022-05402-9","article-title":"Metastatic recurrence in colorectal cancer arises from residual EMP1(+) cells","volume":"611","author":"Ca\u00f1ellas-Socias","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.xpro.2026.104872_bib39","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1158\/0008-5472.CAN-11-4208","article-title":"A preclinical mouse model of invasive lobular breast cancer metastasis","volume":"73","author":"Doornebal","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.xpro.2026.104872_bib40","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41588-025-02496-5","article-title":"Mutational scanning reveals oncogenic CTNNB1 mutations have diverse effects on signaling","volume":"58","author":"Krishna","year":"2026","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xpro.2026.104872_bib41","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41586-025-09733-1","article-title":"Hepatic zonation determines tumorigenic potential of mutant beta-catenin","volume":"649","author":"Raven","year":"2026","journal-title":"Nature"},{"key":"10.1016\/j.xpro.2026.104872_bib42","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2117754119","article-title":"Senescence induction dictates response to chemo- and immunotherapy in preclinical models of ovarian cancer","volume":"119","author":"Paffenholz","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xpro.2026.104872_bib43","doi-asserted-by":"crossref","first-page":"4903","DOI":"10.1038\/s41467-020-18548-9","article-title":"Development of an ObLiGaRe Doxycycline Inducible Cas9 system for pre-clinical cancer drug discovery","volume":"11","author":"Lundin","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xpro.2026.104872_bib44","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41587-023-01783-y","article-title":"A prime editor mouse to model a broad spectrum of somatic mutations in vivo","volume":"42","author":"Ely","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xpro.2026.104872_bib45","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1073\/pnas.1821893117","article-title":"CRISPR-mediated modeling and functional validation of candidate tumor suppressor genes in small cell lung cancer","volume":"117","author":"Ng","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xpro.2026.104872_bib47","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.1038\/s41467-020-19532-z","article-title":"The auxin-inducible degron 2 technology provides sharp degradation control in yeast, mammalian cells, and mice","volume":"11","author":"Yesbolatova","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xpro.2026.104872_bib48","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1038\/s41598-017-01741-0","article-title":"Development of an inducible mouse model of iRFP713 to track recombinase activity and tumour development in vivo","volume":"7","author":"Hock","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xpro.2026.104872_bib49","doi-asserted-by":"crossref","first-page":"10280","DOI":"10.1158\/0008-5472.CAN-05-2193","article-title":"The differential effects of mutant p53 alleles on advanced murine lung cancer","volume":"65","author":"Jackson","year":"2005","journal-title":"Cancer Res."}],"container-title":["STAR Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666166726005253?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666166726005253?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T15:41:41Z","timestamp":1793547701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666166726005253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S2666166726005253"],"URL":"https:\/\/doi.org\/10.1016\/j.xpro.2026.104872","relation":{},"ISSN":["2666-1667"],"issn-type":[{"value":"2666-1667","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modeling human tumor evolution in mice","name":"articletitle","label":"Article Title"},{"value":"STAR Protocols","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xpro.2026.104872","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104872"}}